About Illumina
Illumina, headquartered in San Diego, California, is the global leader in DNA sequencing and array-based technologies that underpin genomics research and clinical diagnostics.
Milestones
Milestones as listed on illumina.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on illumina.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Todd Christian
Products & Services
Products and services as listed on illumina.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
NovaSeq X Plus
High-throughput production-scale sequencing system.
Source: illumina.comNovaSeq 6000
Established high-throughput sequencing platform.
Source: illumina.comMiSeq i100 Series
Compact benchtop sequencers for smaller-scale sequencing runs.
Source: illumina.comInfinium
Microarray platform for genotyping and array-based genomic analysis.
Source: illumina.comDRAGEN
Secondary analysis software for processing sequencing data.
Source: illumina.comBaseSpace
Informatics environment for managing and analysing sequencing data.
Source: illumina.comKits & Reagents
Library preparation, sequencing reagents and microarray kits.
Source: illumina.comFinancials & Irish Entities
From the annual reports Illumina, Inc. files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | $4.34bn | $967m | 22.3% | $850m | 10-K 2026 |
| Dec 2024 | $4.37bn | $1.17bn | 26.7% | −$1.22bn | 10-K 2026 |
| Dec 2023 | $4.50bn | $1.35bn | 30.1% | −$1.16bn | 10-K 2026 |
| Dec 2022 | $4.58bn | $1.32bn | 28.8% | −$4.40bn | 10-K 2025 |
| Dec 2021 | $4.53bn | $1.19bn | 26.2% | $762m | 10-K 2024 |
Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 1 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Illumina Ireland Commercial Limited LTD - Private Company Limited by Shares | 650830 | 2019 | Dec 2025 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Illumina, Inc. as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.